Abstract: The disclosure relates to compositions and methods for preventing, reducing, and/or treating scars. The compositions comprise at least one C-glycoside or derivative thereof, and the methods comprise treating skin and/or scar tissue with at least one C-glycoside or derivative thereof and at least one skin modification stimulus.

Abstract: The disclosure relates to compositions, methods, and kits for improving the appearance of the skin by applying acetyl trifluoromethylphenyl valylglycine, at least one retinoid, and optionally at least one additional skin peeling agent to the skin.

Abstract: The disclosure relates to compositions, methods, regimens, and kits for improving the appearance of the skin by applying acetyl trifluoromethylphenyl valylglycine and at least one peeling agent to the skin.

Abstract: A cosmetic skin-enhancing system confers enhanced skin appearance, including improved facial skin brightness, minimized pore appearance, improved visual smoothness and reduced appearance fine lines and wrinkles. The cosmetic skin-enhancing system includes a skin application regimen, and an article of manufacture for using the cosmetic skin-enhancing system, including at least first and second separately contained compositions including an oxidizing component comprising at least one oxidizing agent and water, and a chemical peel component comprising at least one hydroxy-acid and water, each contained to be separately dispensed for application to skin, in any order, and wherein the skin-enhancing system may be used according to any one of a number of possible application regimens wherein the oxidizing component is used in conjunction with the chemical peel component, applied in sequence, once or, or more frequently, with applications of at least one of the components on a daily basis for a few or several days.

Abstract: A method for improving skin comprising reducing the barrier function of skin, and applying a skin treatment composition to the skin. The skin treatment composition may include about 0.1 to about 25 wt. % of acetyl trifluoromethylphenyl valylglycine; about 0.5 to about 30 wt. % of a polyol; about 0.1 to about 30 wt. % of a silicone, fatty compound, or a mixtures thereof, wherein the skin treatment composition is an emulsion, and all weight percentages are based on the total weight of the skin treatment composition.

Abstract: A method for managing skin tone comprising reducing the synthesis of melanin by applying a skin treatment composition to skin. The skin treatment composition may include about 0.1 to about 25 wt. % of acetyl trifluoromethylphenyl valylglycine; about 0.5 to about 30 wt. % of a polyol; about 0.1 to about 30 wt. % of a silicone, fatty compound, or a mixtures thereof, wherein the skin treatment composition is an emulsion, and all weight percentages are based on the total weight of the skin treatment composition.

Abstract: Disclosed herein are muscle implants and methods of making muscle implants comprising one or more decellularized muscle matrices. The muscle matrices can, optionally, be joined to one or more decellularized dermal matrices. The muscle implants can be used to enhance muscle volume or to treat muscle damage, defects, and/or disorders. The decellularized muscle matrices in the implants retain at least some of the myofibers found in a muscle tissue prior to processing.

Abstract: Disclosed herein are muscle implants and methods of making muscle implants comprising one or more decellularized muscle matrices. The muscle matrices can, optionally, be joined to one or more decellularized dermal matrices. The muscle implants can be used to enhance muscle volume or to treat muscle damage, defects, and/or disorders. The decellularized muscle matrices in the implants retain at least some of the myofibers found in a muscle tissue prior to processing.

Abstract: Disclosed herein are muscle implants and methods of making muscle implants comprising one or more decellularized muscle matrices. The muscle matrices can, optionally, be joined to one or more decellularized dermal matrices. The muscle implants can be used to enhance muscle volume or to treat muscle damage, defects, and/or disorders. The decellularized muscle matrices in the implants retain at least some of the myofibers found in a muscle tissue prior to processing.

Abstract: Nanofibers and microfibers having a core and a polymer shell surrounding the core are provided. The shell includes a plurality of channels that extend from an outer shell surface to the core, and one or more agents, such as pharmacological materials, proteins, viruses, plasmid DNA, bacterial cells, drug-loaded nanoparticles, are encapsulated within the core. The one or more agents discharge from the core through the channels at a controlled rate. The channels are formed by porogen material within the polymer shell.